HCC
BIVV

Hirtle Callaghan & Co’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Hirtle Callaghan & Co’s Portfolio BIVV Stock Details BIVV Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-44
Closed -$3K – 223
2017
Q3 		$3K Hold
44
– – ﹤0.01% 195
2017
Q2 		$2K Sell
44
-10
-19% -$455 ﹤0.01% 185
2017
Q1 		$2K Buy
+54
New +$2K ﹤0.01% 181